Deepecho is proud to announce a new partnership with Rosh Maternal & Fetal Medicine (Rosh MFM), one of the leading maternal-fetal medicine and high-risk pregnancy clinics in New York. Together, we are combining clinical excellence with cutting-edge technology to accelerate the future of AI-powered obstetrics and gynecology

A Leading Clinical Partner in New York

Based in New York City, Rosh Maternal & Fetal Medicine (Rosh MFM) has built a strong reputation as a reference clinic in women’s health, offering world-class care for complex and high-risk pregnancies.

Under the leadership of Dr. Daniel Roshan, CEO and Founder of Rosh MFM, trained in Maternal-Fetal-Medicine at Johns Hopkins University and formerly Director of Perinatology Services at NYU Langone, the clinic provides advanced ultrasound and imaging services, personalized prenatal care, and comprehensive genetic counseling.

With more than two decades of experience in maternal-fetal medicine, Dr. Roshan is widely recognized for his expertise in high-risk obstetrics and maternal-fetal medicine, he has extensive experience managing complex pregnancies involving gestational diabetes, preeclampsia, preterm labor, and genetic conditions. 

This combination of clinical depth, innovation, and patient-centric care makes Rosh MFM an ideal partner for Deepecho’s mission

A Partnership Focused on Innovation

Deepecho and Rosh MFM are partnering to advance fetal medicine through cutting-edge AI innovations, ensuring that these tools are designed to truly serve sonographers and pregnancy specialists. 

The focus will be on deploying, improving and refining algorithms through real-world data and expert feedback, while drawing insights from clinicians and patients to ensure the technology genuinely supports daily medical practice. 

The collaboration will also center on advancing clinical research on cutting edge innovation around new imaging biomarkers for Pre-eclampsia, gestational diabetes or preterm birth. The focus is to deepen the understanding and application of AI in maternal-fetal medicine, alongside creating educational opportunities that help healthcare professionals integrate these tools responsibly and effectively. Ultimately, the partnership aims to strengthen a shared vision of safer, smarter, and more accessible care for mothers and babies worldwide.

Leadership Voices

“I’m very happy to contribute to this collaboration, bringing the best of Deepecho’s technology and working closely with Rosh MFM’s clinical team to redefine what’s possible in maternal-fetal medicine” — Dr. Saad Slimani, Chief Medical Officer, Deepecho

“We’re thrilled to collaborate with Deepecho on this initiative. By combining our clinical expertise with their advanced AI technology, we aim to improve diagnostic accuracy and enhance outcomes for both mothers and babies.” — Dr. Daniel Roshan, Founder & Lead Physician, Rosh MFM